Intellia Therapeutics Inc
F:38I
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Intellia Therapeutics Inc
F:38I
|
US |
|
1st Source Corp
NASDAQ:SRCE
|
US |
|
B
|
Baxter International Inc
F:BTL
|
US |
|
Exxaro Resources Ltd
F:LCQ
|
ZA |
|
Note AB (publ)
STO:NOTE
|
SE |
|
C
|
Celanese Corp
F:DG3
|
US |
|
Microstrategy Inc
BMV:MSTR
|
US |
|
O
|
Overstock.com Inc
F:OVER
|
US |
|
Bank Rakyat Indonesia (Persero) Tbk PT
IDX:BBRI
|
ID |
|
Frontier Group Holdings Inc
NASDAQ:ULCC
|
US |
|
Leone Film Group SpA
MIL:LFG
|
IT |
|
Aptitude Software Group PLC
LSE:APTD
|
UK |
Intrinsic Value
The intrinsic value for 
Intellia Therapeutics Inc (38I) under the Base Case is hidden
EUR.
Compared with the current market price of 11.2 EUR, the stock appears hidden
.
38I looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether 38I usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Intellia Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Intellia Therapeutics Inc
Earnings Waterfall
Intellia Therapeutics Inc
The intrinsic value for Intellia Therapeutics Inc (38I) under the Base Case is hidden EUR.
Compared with the current market price of 11.2 EUR, the stock appears hidden.
